Innovation’ denotes new, better, more effective ways of solving problems. An innovation must be something truly new or at least significantly different, and provide a benefit to the field, with patients at the centre within healthcare domain.
Given the growth of the pharmaceutical segment, the industry needs to become increasingly better at managing pharmaceutical projects for more treatment options to become available to patient populations.
Regulatory bodies (or regulatory agencies) in Life Sciences as we have come to know them have been around since the 1900’s, and they drive how we perform our work. This article is an introduction for those new to the industry and for others interested in the impact of these authorities on innovation.